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All sulfation reactions rely on active sulfate in the form of 3′-phospho-
adenosine-5′-phosphosulfate (PAPS). In fungi, bacteria, and plants, the
enzymes responsible for PAPS synthesis, ATP sulfurylase and adenosine-5′-
phosphosulfate (APS) kinase, reside on separate polypeptide chains. In
metazoans, however, bifunctional PAPS synthases catalyze the consecutive
steps of sulfate activation by converting sulfate to PAPS via the intermedi-
ate APS. This intricate molecule and the related nucleotides PAPS and
3′-phospho-adenosine-5′-phosphate modulate the function of various
enzymes from sulfation pathways, and these effects are summarized in this
review. On the ATP sulfurylase domain that initially produces APS from
sulfate and ATP, APS acts as a potent product inhibitor, being competitive
with both ATP and sulfate. For the APS kinase domain that phosphory-
lates APS to PAPS, APS is an uncompetitive substrate inhibitor that can
bind both at the ATP/ADP-binding site and the PAPS/APS-binding site.
For human PAPS synthase 1, the steady-state concentration of APS has
been modelled to be 1.6 lM, but this may increase up to 60 lM under con-
ditions of sulfate excess. It is noteworthy that the APS concentration for
maximal APS kinase activity is 15 lM. Finally, we recognized APS as a
highly specific stabilizer of bifunctional PAPS synthases. APS most likely
stabilizes the APS kinase part of these proteins by forming a dead-end
enzyme–ADP–APS complex at APS concentrations between 0.5 and 5 lM;
at higher concentrations, APS may bind to the catalytic centers of ATP
sulfurylase. Based on the assumption that cellular concentrations of APS
fluctuate within this range, APS can therefore be regarded as a key modu-
lator of PAPS synthase functions.
Introduction
Sulfated biomolecules are omnipresent in biology. In
vertebrates, bone and cartilage development only func-
tions properly with chondroitin and heparan sulfates
[1], and phase II biotransformation of xenobiotics and
drugs includes sulfation as a key mechanism [2]. The
tissue-specific and systemic activation of steroid hor-
mones is regulated by sulfation [3], major protein com-
ponents of the blood clotting cascade are sulfated, and
human immunodeficiency virus (HIV) needs a sulfated
coreceptor, CXCR5, to invade its host cells [4]. In
Abbreviations
APS, adenosine-5′-phosphosulfate; PAP, 3′-phospho-adenosine-5′-phosphate; PAPS, 3′-phospho-adenosine-5′-phosphosulfate; PAPSS1,
3′-phospho-adenosine-5′-phosphosulfate synthase 1; PAPSS2, 3′-phospho-adenosine-5′-phosphosulfate synthase 2; PPi, pyrophosphate.
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plants, glucosinolates represent a major class of sul-
fated secondary metabolites that mediate interactions
with herbivores and pathogens [5]. In all of these
areas, highly diverse biomolecules are modified by the
attachment of a sulfate group, a central process called
sulfation (also termed sulfonation or sulfurylation). In
humans, > 50 sulfotransferase enzymes are responsible
for various sulfation processes [6], and they can be
found in the cellular nucleus [7], the cytoplasm [8], and
the Golgi apparatus [9]. All eukaryotic sulfotransfe-
rases depend on the provision of active sulfate in
the form of 3′-phospho-adenosine-5′-phosphosulfate
(PAPS) for their proper action. Hence, the importance
of PAPS for sulfation can rival that of ATP for phos-
phorylation processes.
Sulfate needs to be activated, because this highly
stable oxyanion normally resists gentle attempts to
make it undergo chemical bonding. The activation sys-
tem is a multistep process (Fig. 1). First, ATP sulfury-
lase transfers the AMP moiety of ATP onto sulfate,
with concomitant release of pyrophosphate (PPi); the
product is adenosine-5′-phosphosulfate (APS). This
reaction is highly endergonic, so equilibrium resides
mostly at the educt side. It is of interest that the
reverse reaction – starting with APS and PPi, and pro-
ducing ATP – is a key feature utilized by next-genera-
tion sequencing techniques [10]. To thermodynamically
draw the reaction to completion, subsequent steps are
needed for sulfate activation: (a) cleavage of PPi by
ubiquitous pyrophosphatases; (b) an additional phos-
phorylation of the ribose ring catalysed by APS
kinase; and/or (c) reduction of APS or PAPS to sulfite
and further to sulfide-containing metabolites.
The sulfonucleotide APS fulfils multiple roles in this
process. It is the product of the sulfurylase reaction,
and is also a potent product inhibitor of sulfurylase
enzymes in many organisms. In auxotrophic plants
and bacteria, the phosphorylation of APS to PAPS is
not obligatory for reductive sulfate assimilation, as the
exergonic conversion of APS to sulfite by APS reduc-
tase is most probably sufficient to pull the ATP sulfur-
ylase reaction to completion. Hence, APS represents a
metabolic branchpoint for sulfate metabolism in plants
[5]. When APS reduction is not an option, APS kinase
becomes important to pull the sulfurylase reaction by
phosphorylation of the ribose 3′-OH group, finally
yielding PAPS. Generally, APS kinases are also inhib-
ited by APS. Finally, APS has recently been recog-
nized as a specific stabilizer of the human PAPS
synthases, PAPS synthase 1 (PAPSS1) and PAPS syn-
thase 2 (PAPSS2) [11], bifunctional enzymes that con-
sist of ATP sulfurylase and APS kinase domains
connected by a flexible linker. This review highlights
the various regulatory roles of APS in the overall pro-
cess of PAPS biosynthesis. On the basis of consider-
ations about the inhibition of APS kinase and ATP
sulfurylase enzymes, we suggest how PAPS synthase
stabilization by APS may occur mechanistically. Fur-
thermore, the role of the related nucleotides, PAPS
and 3′-phospho-adenosine-5′-phosphate (PAP), in the
regulation of sulfation pathways is also briefly
reviewed.
APS as an inhibitor of the
ATP sulfurylase
ATP sulfurylases are ubiquitous enzymes that catalyze
the first step of biochemical sulfate activation, the
reaction of inorganic sulfate with ATP to form APS
and PPi. The crucial mechanistic feature of this reac-
tion is an ATP-binding mode that is unique to ATP
sulfurylases and different from that of related nucleo-
tidylyl transferases. At the sulfurylase, ATP presum-
ably adopts an unusual U-shaped conformation to
allow the in-line attack of sulfate on the a-phosphorus.
This binding mode was suggested on the basis of an
enzyme–APS–PPi complex of yeast ATP sulfurylase,
on which an enzyme–ATP complex was modelled, as
an ATP complex is not available for any sulfurylase
[12].
ATP sulfurylase enzymes from yeast, fungi and
humans show pronounced product inhibition by APS
[13–15]. Considering the extremely small equilibrium
constant for the APS synthesis direction [16], a very
high affinity for the physiological reaction product of



















Fig. 1. Schematic of sulfate metabolism. Sulfate is converted to
the sulfonucleotide APS (boxed and highlighted in blue) by the
ubiquitous ATP sulfurylase. APS represents a metabolic
branchpoint in bacteria and plants, where it is reduced by APS
reductase (highlighted in grey) to sulfite, and finally incorporated
into primary metabolites after further reduction. Alternatively, APS
is phosphorylated by APS kinase to the universal sulfate donor
PAPS. In metazoans, ATP sulfurylase and APS kinase reside on
one polypeptide, the bifunctional PAPS synthase.
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competitive with both substrates, ATP and sulfate [15],
indicating direct binding to the catalytic center, which
can be visualized in an overlay of several sulfurylase–
APS complex structures (Fig. 2A). In all of these
structures, APS is bound in a conformation that is dis-
tinctively different from the presumed ATP-binding
mode described above. We compared the binding
mode of APS at the sulfurylase with sulfurylase struc-
tures containing sulfate or thiosulfate (Fig. 2B), there
it became apparent that the phosphosulfate precisely
overlayed the bound sulfate group. However, the APS
complex is more compact than the other structures. In
addition, the mode of APS binding was compared with
that of an ADP–sulfurylase complex (Fig. 2C). Unlike
ATP, the ADP molecule is bound in a similar confor-
mation as APS. It is noteworthy that a magnesium ion
is complexed to ADP that is absent in all available
APS–sulfurylase complex structures. This magnesium
ion may be a decisive feature in discriminating between
APS and ADP nucleotides (see below). However, it
has been suggested that the lack of one negative
charge at the b-position (sulfate instead of phosphate)
plays a major role in the enzymatic discrimination
between these two nucleotides [17].
The APS dead-end complex of
APS kinases
APS kinase is responsible for the phosphorylation of
APS at the ribose 3′-OH group, and the structures of
APS kinases from a variety of species are very similar.
Kinetic studies with the enzyme from Penicil-
lium chrysogenum have established an ordered reaction
mechanism, whereby MgATP binds first, followed by
the second substrate APS [20]. After catalysis, PAPS
leaves first, followed by ADP. Other studies on the
APS kinase, however, suggested that ATP and APS
bind to the enzyme in random order [21].
A hallmark of both monofunctional APS kinases
[21–24] and of APS kinase from bifunctional human
PAPS synthase [13] is their pronounced substrate inhi-
bition by APS. This inhibition is uncompetitive in nat-
ure with respect to ATP, suggesting the formation of
the dead-end enzyme–ADP–APS complex after com-
pletion of the enzymatic reaction, when PAPS leaves
the active site and APS rebinds to the same site before
ADP dissociation. The existence of an enzyme–ADP–
APS complex is supported by the highly increased
affinity of APS for an enzyme–ADP complex relative
to the apoenzyme [25,26]. A symmetrical enzyme–
APS–APS complex of the dimeric APS kinase domain
of human PAPSS1 may be taken as a model for this
dead end in the catalytic pathway [27] (Fig. 3). Trun-
cated and point mutants have been reported that lack
substrate inhibition [28], resulting in an asymmetric
dimer structure, similar to the conformation of APS
kinase within the context of the full-length enzyme
[29]. Sekulic et al. concluded that this asymmetry
helped in reducing the substrate inhibition of APS
[28]. Recently reported heterodimers of PAPSS1 and
PAPSS2 – dimeric complexes with inbuilt asymme-
try – did indeed show slightly diminished APS inhibi-
tion [30], with an APS concentration for maximal APS
kinase activity of 15 lM APS. This value was in agree-
ment with previous measurements [13]. When one sub-
unit of dimeric APS kinases is considered at a time, all
three available dead-end complexes show exactly the
same mode of nucleotide binding (Fig. 3).
A B C
Fig. 2. Ligand binding in ATP sulfurylase structures. (A) Three different APS complexes of sulfurylases, from yeast (Protein Data Bank ID
1G8G, green) [12], human PAPS1 (2GIF, cyan) (unpublished), and the fungus P. chrysogenum (1I2D, blue) [18], were overlaid. In all
structures, the APS sulfonucleotide is bound in a very similar manner. (B) The APS complex of yeast sulfurylases (1G8G, green) is overlaid
with two structures of yeast sulfurylase complexed to thiosulfate (1JED, cyan) [19] and sulfate (1G8F, blue) [12]. The APS complex
structure is more compact than the other two structures; however, the positioning of the APS sulfate is very similar to that of sulfate and
thiosulfate. (C) The binding mode of APS (1G8G, green) is compared with that of an ADP–sulfurylase complex (1JED, blue). The two
nucleotides are bound in a nearly identical manner; however, the ADP complex additionally contains a bound magnesium ion.
FEBS Journal (2013) ª 2013 The Authors Journal compilation ª 2013 FEBS 3
J. W. Mueller and N. Shafqat The nucleotide APS modulates PAPS synthases
Bifunctional PAPS synthases are
stabilized by APS
Within the cell, strong product inhibition of the sulfur-
ylase enzyme by APS would not be an obstacle if the
next enzyme in the sulfate activation sequence (APS
kinase) had a high affinity for APS. All vertebrates,
and at least all sequenced invertebrates, including
insects and worms, have bifunctional PAPS synthases
in the form of a C-terminal ATP sulfurylase domain
and an N-terminal APS kinase domain connected by a
short irregular linker [11]. Intermediate channeling has
been suggested for this type of PAPS synthase, as a
possible way to circumvent APS inhibition [31], but
this has been clearly disproved biochemically [13] and
structurally [29] for human PAPSS1. Channeling of
the intermediate APS has unambiguously been shown
only for the differentially arranged ATP sulfurylase/
APS kinase resulting from gene fusions from some
bacteria with an N-terminal sulfurylase and a C-termi-
nal APS kinase domain [16]. A third type of sulfate-
activating enzyme has been described, involving
GTPase activity [16]; these two classes of enzymes are,
however, beyond the scope of this article.
For human PAPS synthases, the maximal attainable
APS kinase activity of recombinant PAPSS1 is clearly
lower than the maximal attainable activity of the ATP
sulfurylase under the same conditions [13]. Because of
this activity imbalance, PAPS synthesis rates within
the cell will depend on an unknown and ever-changing
concentration of the accumulating (and inhibitory)
APS intermediate. Lansdon et al. [13] have calculated
an approximate steady-state APS concentration of
1.6 lM at the PAPSS1 enzyme, which can increase up
to 60 lM under conditions of sulfate excess.
Recently, we made the unexpected observation that
the two human isoforms of PAPS synthase differ
remarkably in their stability towards chemically and
thermally induced unfolding [11]. In a search for stabi-
lizing substances for the PAPS synthases, we tested the
substrates, intermediates and products of PAPS forma-
tion itself for their ability to stabilize these fragile pro-
teins. Sulfate and AMP had no effect on thermal
unfolding transitions of PAPS synthases; ATP had a
slight stabilizing effect on PAPSS2, and moderate
effects on PAPSS1 and PAPSS2 stability were observed
for ADP and PAPS. The sulfonucleotide APS had the
most prominent effect on the unfolding of PAPS synth-
ases (Fig. 4). At equimolar concentrations, APS already
had a remarkable effect on the stability of PAPSS1,
increasing the midpoint of the unfolding transition by
4 °C. APS at 50 lM even caused changes in the overall
form of the unfolding transitions, as it stabilized an
unfolding intermediate by > 16 °C in both PAPS synth-
ases. From the analysis of several point mutants, the
transition stabilization at higher APS concentrations
was attributed to the unfolding of the sulfurylase
domain of bifunctional PAPS synthases [11].
This dual stabilizing effect can now be interpreted in
the light of the above-described inhibition mechanisms.
First, the high-affinity enzyme–ADP–APS complex
forms within the APS kinase domain. Subsequently,
the catalytic centers of ATP sulfurylase are filled with
the competitive inhibitor APS. Such an APS-stabilized
full-length PAPS synthase is possibly best visualized
by reference to the previously reported APS complex
Fig. 3. APS dead-end complexes of APS kinase. Three structures of APS kinase of human PAPSS1 are overlaid, one complexed to two APS
molecules (2OFW, green) [27], one containing an ADP molecule and an APS molecule (1XNJ, cyan) [29], and one crystallized with a desoxy-
ADP (dADP) molecule and an APS molecule (2PEY, blue) [28]. The binding pocket depicted on the left represents the ADP/ATP-binding site.
This pocket is occupied by APS, ADP and dADP, respectively, in the three structures. The binding pocket on the right is the APS/PAPS-
binding site, which is occupied by an APS molecule in all three structures. The structural representations in Figs 2 and 3 were created with
MOLSOFT ICM MOLBROWSER 3.7.
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of PAPSS1 (Fig. 4C) [29]. In that study, the recombi-
nant protein was found to carry a tightly bound ADP
molecule that did not separate during the purification
procedure; this then allowed for the formation of an
enzyme–ADP–APS3 complex upon soaking of the
crystals in 1 mM APS [29]. If this complex corresponds
to the stabilized protein species from our measure-
ments, we also need to have had ADP in our protein
preparations, an assumption that we recently con-
firmed with ion-pairing RP-HPLC analysis, using a
C18 column run in isocratic mode in 50 mM potassium
phosphate (pH 6.6), 10 mM tetrabutylammonium bro-
mide, and 8% acetonitrile, according to [32]. The
ADP/protein ratios were found to be 0.47  0.13 and
0.50  0.10, averaged over three different batches of
PAPSS1 and PAPSS2, respectively, and were in rea-
sonably good agreement with one ADP molecule being
bound per protein dimer. For APS kinase 1 of Arabid-
opsis thaliana, affinity values for different nucleotides
were recently reported [25] that seem to support
our model. The apoenzyme weakly bound APS (Kd =
66.7  10.5 lM); the affinity increased significantly
when the enzyme was preloaded with ADP
(3.3  0.70 lM), and even further in the presence of




What is so special about the sulfonucleotide APS?
The chemical hallmark of sulfate activation is the
phosphoric–sulfuric acid anhydride bond in APS, with
a DG0′ for hydrolysis in the range of 19 kcalmol1
[33]. However, this bond is also present in PAPS, and
both compounds have been considered to be ‘unsta-
ble’. The hydrolysis of phosphosulfate-containing
model compounds has been studied previously. This
bond was recognized to be highly labile to acidic
hydrolysis, but to be stable with half-lives of several
days at pH values > 6.5 [34,35]; this also applied to
various other phosphosulfate-containing nucleotides
(J. Jemielity, personal communication). Moreover,
hydrolysis of the phosphosulfate bond was facilitated
in the presence of divalent metal ions [35,36]; hence,
buffered stock solutions of these compounds should
also contain chelating agents such as EDTA [37].
Accordingly, solutions at pH 8 should be stable when
frozen, and, at refrigerator temperatures, hydrolyze at
a rate of < 1% per day.
The sulfonucleotides APS and PAPS have recently
been synthesized chemically [37], and no differences in
stability between the two compounds were observed
(J. Jemielity, personal communication). This is interest-
ing, because PAPS and APS are commercially available
in strikingly different grades of purity. PAPS lithium
salt (A1651; Sigma, Taufkirchen, Germany) is available
at only 60% purity, and the purity of APS sodium salt
(A5508; Sigma), at ~ 90%, is below the value normally
found for other chemicals. The most likely impurities
are AMP and PAP, the nucleotides remaining after
the hydrolysis of the phosphosulfate moiety. However,
if and why the two compounds should differ in their
stability remains currently unclear.
A B C
Fig. 4. Different stabilities of human PAPS synthases and specific stabilization by APS. (A) Unfolding of human PAPS synthases at
increasing concentrations of urea in the absence of APS. To reach the midpoint of unfolding requires 400 mM less urea for PAPSS2 than for
PAPSS1. (B) Thermal unfolding of human PAPSS1 in the presence of various APS concentrations. Unfolding was monitored by intrinsic
tryptophan fluorescence and CD spectroscopy in (A) and (B), respectively. (C) An APS complex of full-length PAPSS1 has been previously
been reported (1XNJ) [29], and may represent the mechanism by which APS stabilizes PAPS synthases. The two subunits of the dimeric
protein are shown in grey and light blue, the ADP molecule bound to only one of the two APS kinase domains is shown in red, and the
three APS molecules are shown in blue. (A) and (B) were originally published in the Journal of Biological Chemistry [11].  the American
Society for Biochemistry and Molecular Biology.
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Other nucleotides are also effectors
for sulfation pathways
PAPS
Sulfation pathways also involve other nucleotides
that, in return, also profoundly modulate sulfate-acti-
vating enzymes. The ATP sulfurylase enzyme from
P. chrysogenum has an extended C-terminal domain
that is very similar to APS kinases, but is devoid of
APS kinase activity. This domain confers allosteric
regulation to this ATP sulfurylase by PAPS binding
[38]. Other ATP sulfurylases also contain domains
similar to APS kinases, and vice versa [39]; these
may be remnants of ancient bifunctional enzymes
adapted for other purposes. Interestingly, Kopriva
et al. also found increased transcript levels for genes
of glucosinolate biosynthesis in Arabidopsis when
bacterial APS kinase was overexpressed [5]. Glucosin-
olates constitute a major class of sulfated secondary
metabolites in plants, and their biosynthesis requires
PAPS as the sulfate donor. From their findings, they
concluded that PAPS or its derivatives may be
involved in cellular signalling in plants [5]. In anal-
ogy to this, negative feedback regulation might also
play a role in mammalian cells to elicit a transcrip-
tional response upon low APS levels, to increase
overall PAPS synthesis.
PAP
Yet another nucleotide may be important for a func-
tional understanding of PAPS synthases: PAP. This is
the residual product when a sulfotransferase uses
PAPS for biological sulfation. Several studies have
reported regulatory roles for PAP in drought and
high-light signalling in Arabidopsis [40], or more gener-
ally for stress-responsive gene expression in plants [41].
Moreover, high PAP concentrations were reported to
be toxic in bacteria, owing to inhibition of RNA 5′–3′-
exonucleases [42] and PAPS reductases. However, PAP
does not directly have a strong effect on human PAPS
synthase stability [11]. PAP may be subject to degrada-
tion by various bisphosphatases, another emerging
field that has been reviewed recently [43].
Future directions
PAPS synthases seem to actively shuttle between the
nucleus and cytoplasm [44], and it remains to be seen
whether high or low cellular APS levels influence this
localization pattern. Stabilization and inhibition by the
sulfonucleotide APS is surely not the only way in
which PAPS synthase function is modulated. Within
the cell, PAPS synthases may also associate with chap-
erones or other stabilizing proteins. The first attempts
to find such proteins by yeast two-hybrid screens did
not result in plausible interaction partners [45]. How-
ever, on the basis of triple fusion proteins of APS
kinase, ATP sulfurylase and pyrophosphatase within
the genomes of the fully sequenced marine diatoms
Thalassiosira pseudonana and Phaeodactylum tricornu-
tum [46], a functional interaction with pyrophospha-
tase has been suggested [47]. Such triple gene fusion in
algae may be especially interesting, as diatoms and
haptophytes reduce APS and not PAPS, so the APS
kinase reaction of this complex seems to be not actu-
ally required in this case.
APS and the related nucleotides PAPS and PAP
modulate the functions of various enzymes from sulf-
ation pathways. For bifunctional PAPS synthases,
which are at the heart of mammalian sulfation reac-
tions, APS is not only an intermediate of overall PAPS
production, but also serves as an inhibitor of the sul-
furylase and the APS kinase activities, and as a stabi-
lizer for the fragile PAPS synthases. Changing
intracellular concentrations of the sulfonucleotide APS
(and putatively also of other nucleotides involved)
may have a tremendous influence on cellular sulfation
processes. However, intracellular concentrations for
these metabolites have not yet been quantified.
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